Supplementary Tables – Biomarker subset analysis of a Phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients with EGFRm+ NSCLC
收藏数据链接：
官方服务：
资源简介：
<b>Supplementary Table 1. TRAEs occurring in ≥10% of patients.</b> <b>Supplementary Table 2. Subgroup analysis of TTSP and PFS in biomarker group.</b>
提供机构：
Future Science Group创建时间：
2022-05-03
